Home » Newsletters » BioWorld

BioWorld

Sep. 27, 1991

View Archived Issues

ANALYST DOWNPLAYS GM-CSF PATENT NEWS

CHIRON/CETUS MERGER PASSES FTC DEADLINE

CENTOCOR RAISES SIZE OF DEBENTURES

EPITOPE GETS GRANT FOR HIV TEST

MGI GETS RIGHTS TO PILOCARPINE MOUTHWASH

HEMACARE EXTENDS WARRANT EXPIRATION

OXFORD COMPLETES $8M FINANCING

SBIR GRANTED FOR AMYLIN MABS

FDA PANEL RECOMMENDATION SPURS CHIRON

SUITS OPPOSE GI MERGER WITH AHP

COMBINATION TEST APPROVED FOR HIV-1, 2

MULTIDRUG STRATEGY TO COMBAT AIDS

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 6, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...